BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2416361)

  • 21. Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
    Gallistl S; Muntean W
    Thromb Haemost; 1994 Sep; 72(3):387-92. PubMed ID: 7855789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy-associated plasma protein A (PAPP-A) in non-pregnant subjects.
    Bersinger N; Klopper A
    Br J Obstet Gynaecol; 1984 May; 91(5):453-6. PubMed ID: 6202314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental protein 5 is related to blood coagulation and fibrinolytic systems.
    Siiteri JE; Koistinen R; Salem HT; Bohn H; Seppälä M
    Life Sci; 1982 May; 30(22):1885-91. PubMed ID: 6213827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity.
    Béguin S; Kessels H; Dol F; Hemker HC
    Thromb Haemost; 1992 Aug; 68(2):136-42. PubMed ID: 1412157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant activity of a bacterial glycopeptide.
    Akoum A; Josefonvicz J; Sigot M
    Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme immunometric assay for the determination of pregnancy associated plasma protein A (PAPP-A) with the antigen as solid phase (conjoint IEMA).
    Bersinger NA
    Experientia; 1984 Sep; 40(9):1022-4. PubMed ID: 6205894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide derivative (1-70 fragment) of protein SV-IV accelerates human blood coagulation in vitro by selective inhibition of the heparin-induced antithrombin III activation process.
    Di Micco B; Stiuso P; Colonna G; Porta R; Marchese M; Schinina ME; Macalello MA; Metafora S
    J Pept Res; 1997 Feb; 49(2):174-82. PubMed ID: 9147313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of pregnancy-associated plasma protein A (PAPP-A) in placentae from normal and pre-eclamptic pregnancies.
    Dobashi K; Ajika K; Ohkawa T; Okano H; Okinaga S; Arai K
    Placenta; 1984; 5(3):205-12. PubMed ID: 6209702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-site enzyme immunoassay for pregnancy associated plasma protein A (PAPP-A).
    Bersinger NA
    Clin Chim Acta; 1983 Nov; 134(3):297-306. PubMed ID: 6196143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological heterogeneity of pregnancy-associated plasma protein-A (PAPP-A). Effects on the radioimmunoassay of PAPP-A.
    Bischof P; Meisser A
    Br J Obstet Gynaecol; 1989 Jul; 96(7):870-5. PubMed ID: 2475161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of lymphocyte transformation by pregnancy-associated plasma protein-A (PAPP-A).
    Boschof P; Lauber K; de Wurstemberger B; Girard JP
    J Clin Lab Immunol; 1982 Jan; 7(1):61-5. PubMed ID: 6175757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum PAPP-A in normal pregnancy: relationship to fetal and maternal characteristics.
    Westergaard JG; Teisner B; Grudzinskas JG
    Arch Gynecol; 1983; 233(3):211-5. PubMed ID: 6194761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a radioimmunoassay for pregnancy-associated plasma protein A and establishment of normal levels in the first trimester of pregnancy.
    Anthony F; Masson GM; Wood PJ
    Ann Clin Biochem; 1983 Jan; 20 Pt 1():26-30. PubMed ID: 6188409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of pregnancy associated plasma protein A (PAPP-A).
    Bischof P; Bruce D; Cunningham P; Klopper A
    Clin Chim Acta; 1979 Jul; 95(2):243-7. PubMed ID: 93522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placenta-associated plasma protein-A (PAPP-A, SP4) in trophoblastic tumours.
    Wahlström T; Teisner B; Lee JN; Grudzinskas JG; Seppälä M; Folkersen J
    Acta Pathol Microbiol Scand A; 1981 Jan; 89(1):65-6. PubMed ID: 6164245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the concentration of pregnancy-associated plasma protein-A during normal and complicated pregnancy.
    Sutcliffe RG; Kukulska-Langlands BM; Horne CH; Maclean AB; Jandial V; Sutherland HW; Gibb S; Bowman AW
    Placenta; 1982; 3(1):71-80. PubMed ID: 6176990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between heparin and human pregnancy-associated plasma protein A (PAPP-A): a simple purification procedure.
    Davey MW; Teisner B; Sinosich M; Grudzinskas JG
    Anal Biochem; 1983 May; 131(1):18-24. PubMed ID: 6193728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.